M. Naarding

发表

Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.

E. Falkowska, Hui Xiao, T. Dragic, 2011, Vaccine.

Bile Salt-Stimulated Lipase from Human Milk Binds DC-SIGN and Inhibits Human Immunodeficiency Virus Type 1 Transfer to CD4+ T Cells

W. Paxton, T. Geijtenbeek, A. Dirac, 2006, Antimicrobial Agents and Chemotherapy.

Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

B. Berkhout, W. Paxton, T. Geijtenbeek, 2005, The Journal of clinical investigation.

Chloroquine Administration in Breastfeeding Mothers Associates with Increased HIV-1 Plasma Viral Loads

W. Paxton, J. Beijnen, F. Wit, 2020 .

In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

H. Schuitemaker, D. Schols, R. V. van Rij, 2004, Journal of Virology.

Binding of Human Milk to Pathogen Receptor DC-SIGN Varies with Bile Salt-Stimulated Lipase (BSSL) Gene Polymorphism

R. Lyle, W. Paxton, M. Tanck, 2011, PloS one.

Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes

W. Paxton, G. Pollakis, M. Naarding, 2007, Retrovirology.

Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.

J. Kappes, O. Anzala, T. Hanke, 2014, Journal of immunological methods.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

J. Excler, P. Fast, P. Hayes, 2012, PloS one.